Sonitus Medical Revenue and Competitors
Estimated Revenue & Valuation
- Sonitus Medical's estimated annual revenue is currently $7.8M per year.
- Sonitus Medical's estimated revenue per employee is $251,000
Employee Data
- Sonitus Medical has 31 Employees.
- Sonitus Medical grew their employee count by -3% last year.
Sonitus Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Staff Dentist | Reveal Email/Phone |
Sonitus Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Sonitus Medical?
Sonitus Medical is committed to providing advanced hearing solutions that hearing professionals such as Otologists, ENTs, and Audiologists can use to help their patients rejoin the conversation of life. Our SoundBiteâ„¢ prosthetic device is the world's first non-surgical and removable hearing solution that relies on bone conduction to imperceptibly transmit sound via the teeth. SoundBite is currently FDA cleared for the treatment of single sided deafness and Conductive Hearing Loss.
keywords:N/AN/A
Total Funding
31
Number of Employees
$7.8M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sonitus Medical News
2022-04-20 - Le marché des aides auditives à ancrage osseux va assister à ...
Les principaux acteurs clés présentés dans ce rapport sont: GN Store Nord, MED-EL, Sonitus Medical, William Demant, Sophono, Cochlear. Les...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.7M | 31 | 7% | N/A |
#2 | $4.5M | 31 | -9% | N/A |
#3 | $7.2M | 31 | 0% | N/A |
#4 | $8M | 31 | -44% | N/A |
#5 | $6M | 31 | -22% | N/A |